This year Anabiotec-Anacura is golden sponsor
Moving your therapeutic protein into clinic requires additional stability and release testing under GMP conditions.The Research Institute for Chromatography and Anabiotec join forces to offer you a full analytical path for your biological compound from characterisation up to release, including chromatographic method development and LC-MS troubleshooting.
Come and discover during this workshop how the integration of expertise helps to timely deliver high quality results.
Marc De Weer, Galapagos
Marc De Weer is industrial pharmacist, Head of CMC Development at Galapagos and has over 20 years experience in pharmaceutical industry. Previously he held different positions at Janssen Pharmaceutica (J&J) in commercial manufacturing, quality and pharmaceutical development.
Griet Nuytinck, Anacura
Griet Nuytinck is Managing Director of Anacura, an independent analytical lab offering a broad range of highquality pharmaceutical and medical analyses. As a specialist in laboratory medecine and industrial pharmacist, Griet has always been interested in both medical and pharmaceutical perspectives of healthcare. Over the last three decades she founded Labo Nuytinck (Anacura Medical), specialised in laboratory medecine and cofounded a pharmaceutical lab, Anabiotec (Anacura Life Sciences).
Dr. Filip Borgions, Argenx
Dr. Filip Borgions is Director CMC at Argenx, a biotech company focusing on the clinical development of therapeutic antibodies in oncology and severe auto-immune diseases. He is responsible for the CMC development of Argenx clinical assets and has over 12 years of experience in the field of protein characterisation and biologicals process development and commercial manufacturing.
Dr. Koen Sandra, RIC
Koen Sandra is Scientific Director, Research Institute for Chromatography (RIC). He received a PhD degree in Biochemistry from the Ghent University, Belgium in 2005. After his PhD, he joined Pronota, a molecular diagnostics company where he was active in developing analytical platforms. In 2008, he joined the Research Institute for Chromatography (RIC), a company that provides world-class chromatographic and mass spectrometric support to the chemical, life sciences and (bio)pharmaceutical industries.
Dr. Katleen Broos, Anacura
Biochemist, PhD and Business Innovation Manager Biologics at Anacura. Previously she worked as Project Manager at Anabiotec and held different academic positions: Katleen was responsible for projects ranging from the expression and purification of virus like particles over the role of novel receptors in blood platelet physiology to xenotransplantation of transduced stem cell transduction.